Which Weight Management Medication Offers Better Value in 2026?
Understanding the Wegovy Price Increase Landscape Against Mounjaro
The wegovy price increase has prompted many patients to explore alternatives, with Mounjaro emerging as a popular comparison point. Unlike Wegovy's semaglutide (a GLP-1 receptor agonist), Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors simultaneously. This dual-action mechanism creates a different therapeutic profile, though both remain prescription-only medicines requiring careful clinical assessment. The wegovy price increase reflects growing demand and manufacturing costs, but when comparing value, it's essential to consider the complete treatment pathway rather than individual pen prices.
Wegovy follows a structured 5-dose escalation from 0.25mg to 2.4mg over 16 weeks, whilst Mounjaro offers 6 dose levels from 2.5mg to 15mg. This difference in dosing architecture affects both the wegovy price increase impact and overall treatment costs. At EverydayMeds, we've maintained competitive pricing for both medications, ensuring patients aren't disadvantaged by market fluctuations whilst receiving the same high-quality, temperature-controlled supply chain that both medicines require.
Wegovy Price Increase: Complete Cost Breakdown and Bundle Savings
Despite the wegovy price increase, our pricing structure remains transparent and competitive. Single pens start at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25, with these codes already factored into our listed prices. Our bundle options provide convenience through reduced ordering frequency rather than focusing purely on cost savings.
The wegovy price increase becomes more manageable through our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg pens) for £169.99, providing 8 weeks of initial treatment. For maintenance patients concerned about the wegovy price increase at higher doses, our Ultimate Stability Trio offers three months of 2.4mg supply for £649.99. Mounjaro pricing follows a different structure, and your prescriber can help determine which medication offers the best value based on your individual response and tolerance profile.
Clinical Evidence Behind Wegovy Price Increase Justification
The wegovy price increase reflects robust clinical evidence from the STEP trial programme, demonstrating significant efficacy in weight management. In the pivotal STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight loss of approximately 15.2% at two years, suggesting long-term value despite the wegovy price increase.
Mounjaro's evidence comes from the SURMOUNT trials, showing different efficacy profiles that may justify its own pricing structure. However, comparing trial results directly isn't appropriate due to different study designs and populations. Both medications represent significant clinical advances in weight management, and the wegovy price increase should be viewed alongside the substantial healthcare cost savings that effective weight management can provide through reduced comorbidity risks.
How Wegovy Works: Understanding Value Beyond Price Increases
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones produced in the intestine. When you inject Wegovy weekly, it activates GLP-1 receptors in the brain's appetite centres, particularly the hypothalamus, reducing hunger signals and promoting feelings of fullness after smaller meals. This mechanism may also reduce food cravings and slow gastric emptying, helping you feel satisfied longer between meals. The medication works by essentially restoring normal appetite regulation that may be disrupted in obesity, rather than artificially suppressing appetite. Understanding this sophisticated mechanism helps justify the wegovy price increase, as you're paying for advanced biotechnology that addresses the biological drivers of weight gain.
Streamlined Ordering Process Despite Wegovy Price Increase
At EverydayMeds, we've maintained our efficient ordering process despite market-wide pricing pressures from the wegovy price increase. Begin with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our UK-registered prescribers (working under GPhC #9012878) typically review applications within 3 working days, with express 24-hour service available for urgent orders. Once approved, your Wegovy ships via next-day delivery using specialist cold-chain logistics to maintain the 2-8°C temperature requirement. This streamlined process ensures the wegovy price increase doesn't create additional delays or administrative burdens for patients starting their weight management journey.
Storage and Practical Considerations Affecting Long-term Costs
Wegovy offers practical advantages that can offset the wegovy price increase through reduced wastage and greater flexibility. Each pen stores in your fridge at 2-8°C until first use, but crucially can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration. This compares favourably to Mounjaro's 21-day room temperature limit, potentially reducing medication waste during travel or power outages. The FlexTouch pen design ensures accurate dosing throughout the escalation schedule, from starter 0.25mg through to maintenance 2.4mg. Proper storage and handling practices maximise the value of each pen, making the wegovy price increase more acceptable when medication isn't lost to temperature excursions or dosing errors.
Wegovy Price Increase vs Mounjaro: Making the Right Choice
When evaluating the wegovy price increase against Mounjaro alternatives, consider that both medications serve different patient populations optimally. Wegovy's established track record and extensive real-world usage data provide confidence for many prescribers, whilst Mounjaro's dual GLP-1/GIP mechanism may suit patients who haven't responded well to GLP-1-only treatments. The wegovy price increase shouldn't be the sole deciding factor, as individual response, side effect profiles, and injection frequency preferences all influence long-term treatment success.
At EverydayMeds, we stock both options specifically because no single weight management medication suits every patient. Your prescriber can help navigate the wegovy price increase considerations alongside clinical factors to identify the most cost-effective treatment for your circumstances. Both medications require identical lifestyle modifications and clinical monitoring, ensuring you receive comprehensive support regardless of which prescription-only medicine proves most suitable.
Securing Your Supply: Discount Codes and Final Steps
Ready to start your weight management journey despite the wegovy price increase? New customers apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 to access our competitive pricing structure. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and compare both Wegovy and Mounjaro options side-by-side. Our GPhC-registered pharmacy team ensures every order meets stringent quality standards, from prescription verification through temperature-controlled dispatch. Remember that effective weight management represents a long-term investment in your health, and the wegovy price increase should be viewed alongside the substantial benefits that successful treatment can provide. Whether you choose Wegovy or Mounjaro, you're accessing evidence-based medication that works alongside a reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
